Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study

By Joong-Won Park, Minshan Chen, M. Colombo, Lewis R. Roberts, M. Schwartz, Pei-Jer Chen, M. Kudo, P. Johnson, S. Wagner, L. Orsini and 1 more. Liver international (Print), 2015

1,194 citations recorded by the source corpus.

Hepatocellular carcinoma (HCC) is the second most common cause of cancer deaths worldwide. The global HCC BRIDGE study was a multiregional, large‐scale, longitudinal cohort study undertaken to improve understanding of real‐life management of patients with HCC, from diagnosis to death.

Subfields: Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/1226f36007835249f67b5ae911b4ed09fbb92ca3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. J. Llovet
2. Peter R. Galle
3. Amit G. Singal
4. V. Mazzaferro
5. F. Kanwal
6. Alejandro Forner1 , 2

In Hepatology

1. J. Llovet
2. V. Mazzaferro
3. Alejandro Forner1 , 2
4. Peter R. Galle
5. Amit G. Singal
6. F. Piscaglia
7. J. Raoul
8. F. Kanwal

Citations in the corpus

• EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. (2018, background): “J Hepatol (2018), https:// Clinical Practice Guidelines non-subcapsular HCCs.475 Various authors have shown that there were no significant differences in OS, local tumour progression, and major complication rates between the two groups.475,476 It is worth remembering that some tumour location issues”
• Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy (2023, background): “…in most parts of Africa, and aflatoxin exposure might be responsible for the young age of onset of HBV-associated HCC in sub-Saharan Africa 30 , where the median age at HCC diagnosis is 45 years compared with 52, 69, 65 and 62 years in China, Japan, Europe and North America, respectively 45,46 .”